SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?


To: dowman who wrote (9561)6/29/1998 8:16:00 PM
From: Scott H. Davis  Respond to of 14328
 
Buffet uses a value screen in weighing his investments that TRIBY would not meet. FYI, in discussing undervalued companies, the following is an earnings release from another foreign exchange stock with much more financial disclosure AND some serious EPS vs TRIBY despite trading in the same price range (.31 CDN for the year, .18 CDN for the qtr) FYI Scott

biz.yahoo.com



To: dowman who wrote (9561)6/29/1998 10:36:00 PM
From: Ron Luhmann  Read Replies (1) | Respond to of 14328
 
four years ago TRIBY lost .29/share on 5,992,904 shares
and I know you weren't around then...I was...boy do I long
for those days again...yeah right...you're obviously
obsessed with the number of shares and can't get beyond
that...or acknowledge the awesome achievements of TRIBY
since then...without the cash for R&D, new products (90 and
growing), acquisitions (Jamestown, Centacor), new employees
(from 34 to 175+), stock deals (SLF shares) and new production facilities (Bray+ weekend shifts to keep up with orders), I submit TRIBY would not have survived..as many small biotech's don't much less be profitable and gaining each Qtr...and now you're an authority on what Warren Buffett's definition of what quality is...he invests for several years in companies & countries that are not in vogue...my return on TRIBY from 31/32 to over $5 from '94 to '96...and I didn't sell at the top will be duplicated again...after we dispose of the chickens running to the hen house with the next acquisition and pop in share price we will be rewarded with Unigold approval and get beyond $3 for good...next stop $10 plus...my opinion...maybe 2 years away...I'll gladly wait again for a 5 banger or better!!... GO TRIBY !!! :-)



To: dowman who wrote (9561)6/29/1998 10:40:00 PM
From: DMore  Read Replies (1) | Respond to of 14328
 
The increase is shares was mainly for acquisitions.
This can't be measured immediately. I will give them
at least a year from the acquired dates to allow for
synergy. By then real eps should be seen from them
and rev increases seen. Then we can better judge the
success or failure of more shares for more business.
I believe rev and inc growth rates will show dramatic
growth in the coming 2-3 years. If this occurs and I
see $10 from here, then the wait was worth it.
25 to 30 cents per share should justify $10 on a growth
stock.
D